Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Royalty Pharma has secured a significant royalty interest in AstraZeneca's cliramitug, a promising Phase 3 therapy targeting transthyretin amyloidosis with cardiomyopathy (ATTR-CM), by acquiring part of Neurimmune’s royalty rights for up to $425 million. Cliramitug represents a first-in-class approach aimed at removing amyloid deposits rather than …
uniQure N.V., a gene therapy company specializing in transformative treatments, announced it will release its second quarter 2026 financial results before market open on July 29, 2026, followed by a management conference call. The company highlighted its approval for gene therapy in hemophilia B and ongoing development for other severe diseases.
Western Alliance (WAL) looks positioned to see a near-term relief rally if Q2 results provide clarity on recent loan losses and CRE exposure. The bank trades at ~9x earnings and 1.15x book with a $8.8B market cap. This trade idea is a tactical long: enter near $79.00, stop at $72.00, target $92.00 over a 180-trading-day horizon, with clear risk man…
Oatly Group AB reported second quarter 2026 financial results with revenue of $240.1 million, a 15.2% increase year-over-year, driven by strong growth in Europe, North America, and Greater China. The company improved gross margin to 33.9% and narrowed net loss to $31.3 million from $55.9 million a year ago. Adjusted EBITDA improved to a slight posi…
Stifel Financial Corp. reported net revenues of $1.45 billion and net income of $217.2 million for Q2 2026, marking the best second quarter in company history. Significant growth was driven by increased investment banking revenues, asset management, and commission revenues. The company also achieved record client assets, improved operating leverage…
Advantage Solutions Inc., a leading omnichannel retail solutions agency, will report its second quarter 2026 financial results on August 5, 2026, followed by a conference call and webcast for investors and interested parties. The company provides data and technology-powered services to consumer-packaged goods brands and retailers to drive demand an…
Rogers Communications released its Q2 2026 results showing strong growth in total service revenue (+8%) and adjusted EBITDA (+3%), with stable wireless revenue and growth in cable and media segments. The company completed an agreement to acquire the remaining 25% stake in Maple Leaf Sports & Entertainment, positioning it for further sports monetiza…
Fidelity D & D Bancorp, Inc. reported robust second quarter and first half 2026 results, with net income increasing 13% in Q2 and 19% year-over-year. Growth was driven primarily by a substantial increase in net interest income due to higher loan balances and improved yields, alongside modest increases in non-interest income, particularly from wealt…
Avalo Therapeutics, a clinical-stage biotech focused on IL-1β pathway therapeutics for immune-mediated inflammatory diseases, announced CEO participation in a BTIG Biotechnology Conference panel and one-on-one investor meetings. The company recently reported positive Phase 2 data for its lead candidate, abdakibart, in hidradenitis suppurativa and i…
Geron Corporation, a commercial-stage biopharmaceutical company specializing in blood cancer treatments, announced it will release its Q2 2026 financial results and business highlights on August 5, 2026. The company will host a conference call and webcast to discuss the results. Geron focuses on its telomerase inhibitor drug RYTELO® (imetelstat), a…
Coherent Corp., a leader in photonics technology, announced it will release its financial results for Q4 and fiscal year 2026 on August 12, 2026, after the NYSE closes, followed by a live webcast to discuss the results. The company highlights its position across data center, communications, and industrial markets, supporting ongoing innovation.
OKYO Pharma's Chief Medical Officer, Dr. Flavio Mantelli, has purchased 20,000 shares of the company at $1.40 per share. This insider buying occurs as the company prepares to initiate a global Phase 3 clinical trial for urcosimod, targeting neuropathic corneal pain. The move signals confidence in the upcoming pivotal study and the company’s therape…
Standard BioTools Inc., a life science tools company listed on NASDAQ under the ticker LAB, announced it will release its second quarter 2026 financial results after the U.S. market closes on August 5, 2026. The company specializes in providing standardized next-generation solutions to biomedical researchers to accelerate therapeutic development.
AmpliTech Group announced that its new Outdoor Macro Cell 4T8R Open RAN Radio Unit has received FCC approval in the U.S. and ISED certification in Canada, enabling deployment across North America. The AI-ready 4T8R architecture offers improved network performance and cost efficiency, positioning AmpliTech to capitalize on expanding 5G, Open RAN mod…
Radiopharm Theranostics announced positive Phase 2b trial results for RAD101, a novel PET imaging agent targeting fatty acid synthase, demonstrating 93% concordance with MRI and 86% sensitivity in detecting recurrent brain metastases. The company plans to initiate a US Phase 3 pivotal trial in Q4 2026, addressing a significant unmet need in neuro-o…
BioCryst Pharmaceuticals, a US-based biotechnology company specializing in treatments for rare diseases like hereditary angioedema, announced it will report its second quarter 2026 financial results on August 5, 2026. The company plans to host a conference call and webcast to discuss the results and provide a corporate update.
NOVAGOLD RESOURCES INC. announced an all-share transaction to acquire Paulson's 40% stake in Donlin Gold, increasing NOVAGOLD's ownership to 100%. The new entity, NovaGold Corporation, will be U.S.-domiciled and listed on NYSE, consolidating control to streamline development and financing of Donlin Gold—projected to be the largest gold mine in the …
Old National Bancorp, a top 25 U.S. bank, reported record second quarter 2026 net income applicable to common shares of $249.4 million with diluted EPS of $0.65, driven by strong loan growth, stable net interest margin, disciplined expense management, and robust credit quality. The company also announced an enhanced executive leadership structure t…
Pharvaris, a Nasdaq-listed late-stage biopharmaceutical company, announced a publication in Clinical Reviews in Allergy & Immunology providing an in-depth review of the bradykinin B2 receptor's role in bradykinin-mediated angioedema and other immunological diseases. The article consolidates decades of research supporting the bradykinin B2 receptor …
Latvian soldiers used tear gas and discharged a warning shot to stop a group of migrants attempting to cross from Belarus after they behaved aggressively and threw logs at troops, the army said. Prime Minister Andris Kulbergs has warned that attempted crossings from Belarus have recently doubled and said Latvia has increased border security in resp…
Wrap Technologies just cleared a large regulatory hurdle with an ATF ruling classifying the BolaWrap 150 as an instrument of restraint, not a firearm. That clarity shortens procurement cycles and opens federal, corrections, healthcare and international channels. With Q1 revenue up 45% YoY, $3.2M in bookings, and improved cash burn, the upgrade to a…
The World Bank's chief economist cautioned that an intensification of conflict between the United States and Iran could propel global headline inflation toward 4.5%, drive policy rates higher and depress worldwide growth to as little as 1.3% in 2026. In a late-July interview, he said the bank's downside scenario - with fighting lasting six months o…
A Manhattan federal judge has scheduled a June 1, 2027 trial date for ousted Venezuelan President Nicolas Maduro and his wife Cilia Flores on U.S. drug trafficking charges. The court also established deadlines for defense motions, including an immunity challenge, and for production of evidence that may include classified material. Maduro and Flores…
President Donald Trump held a campaign rally in Marietta, Georgia, reiterating calls for stricter nationwide voting rules and renewing criticisms of the state's 2020 election handling. His remarks, part of an extended focus on election security, have prompted anxiety among some Georgia Republicans who say the rhetoric could discourage supporters fr…
A State Department cable dated July 16 directed U.S. diplomats to rebut international claims that Washington wields a 'kill switch' over American technology, following a brief decision that blocked foreigners from accessing leading AI models. The guidance frames short pauses and voluntary testing windows as safety measures rather than tools of coer…
